Catalyst Pharmaceuticals, Inc. (CPRX): A Bull Case Theory
We came across a bullish thesis on Catalyst Pharmaceuticals, Inc. on BioEquity Watch’s Substack. In this article, we will summarize the bulls’ thesis on CPRX.
Catalyst Pharmaceuticals Inc. (CPRX)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Renaissance Technologies Jim Simons | 2,650,077 | $61,852,797 | -26% | 0.1% |
| 2. | Royce & Associates Chuck Royce | 1,910,767 | $44,597,302 | -7% | 0.45% |
| 3. | Arrowstreet Capital Peter Rathjens, Bruce Clarke And John Campbell | 1,617,208 | $37,745,635 | +24% | 0.02% |
| 4. | Winton Capital Management David Harding | 353,529 | $8,251,367 | +547% | 0.28% |
| 5. | Dorset Management David M. Knott | 189,000 | $4,411,260 | 2.04% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $2.99 | 7,000 | $20,930.00 | 560,376 | 2020-09-30 | Filing | |
| $2.97 | 15,000 | $44,550.00 | 4,787,693 | 2020-09-30 | Filing | |
| $4.70 | 10,000 | $46,950.00 | 553,376 | 2019-10-11 | Filing | |
| $4.89 | 10,000 | $48,900.00 | 4,772,693 | 2019-10-03 | Filing | |
| $3.23 | 25,000 | $80,750.00 | 4,762,693 | 2019-06-11 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $23.06 | 6,746 | $155,562.76 | 2,360 | 2025-12-12 | Filing | |
| $23.73 | 4,473 | $106,162.18 | 9,106 | 2025-12-12 | Filing | |
| $23.20 | 15,527 | $360,195.35 | 13,579 | 2025-12-12 | Filing | |
| $23.33 | 10,983 | $256,244.37 | 3,962 | 2025-11-26 | Filing | |
| $22.70 | 40,000 | $908,000.00 | 231,039 | 2025-11-12 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 18,626,781 | $434,749,068 | 0.01% | |
| 2. | 8,432,247 | $196,808,646 | 0% | |
| 3. | 6,907,622 | $161,223,897 | 0.01% | |
| 4. | 3,025,271 | $70,609,825 | 0.04% | |
| 5. | 2,996,297 | $69,932,608 | 0.01% |
News See All
7 Stocks on Jim Cramer’s Radar Recently
“The market gets so angry over nothing. It's just plain irritable, very hard to please, like a 3-year-old child. But when you make it happy, the inner child giggles, and your stocks will soar.
Analysts See Big Upside in Catalyst Pharmaceuticals, Inc. (CPRX)
Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) is among the cheap healthcare stocks to buy heading into 2026. As of December 7, Catalyst Pharmaceuticals, Inc.
12 Cheap Healthcare Stocks to Buy Heading into 2026
Since the pandemic, healthcare is one of the sectors that have remained in the spotlight even amid market twists.
Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Q3 2025 Earnings Call Transcript
Operator: Greetings, and welcome to the Catalyst Pharmaceuticals Third Quarter 2025 Financial Results Conference Call and webcast. [Operator Instructions].
What do Analysts Think About Catalyst Pharmaceuticals (CPRX)?
Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) is one of the best biotech stocks with high potential. HC Wainwright reiterated a Buy rating on Catalyst Pharmaceuticals, Inc.
14 Biotech Stocks with High Potential
Healthcare was the second worst performer this year, with pharma and biotech companies under pressure.
Catalyst Pharmaceuticals, Inc. (CPRX) Secures FIRDAPSE Market Exclusivity Until 2035
Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) is a commercial-stage biopharmaceutical company specializing in treatments for rare and difficult-to-treat diseases.
11 Cheap Biotech Stocks to Buy According to Hedge Funds
Mizuho's Jared Holz appeared on CNBC's "Closing Bell Overtime" on July 8 to talk about whether the biotech industry is prepared for a breakthrough.
Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Q2 2025 Earnings Call Transcript
Operator: Greetings, and welcome to the Catalyst Pharmaceuticals Second Quarter 2025 Financial Results Conference Call. [Operator Instructions] As a reminder, this conference is being recorded.
Hedge Fund Resource Center Billionaire Hedge Funds
